These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29055921)

  • 21. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
    Fabrizi F; Martin P; Messa P
    Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Gerosa S; Vinson S; Mousa M; Gitnick G
    Nephron; 1998 Dec; 80(4):428-33. PubMed ID: 9832642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of acute HCV infection in hemodialysis patients.
    Espinosa M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Rodriguez M; Aljama P
    Clin Nephrol; 2002 Aug; 58(2):143-50. PubMed ID: 12227687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
    Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
    J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.
    Fabrizi F; Donato FM; Messa P
    Int J Artif Organs; 2017 Oct; 40(10):531-541. PubMed ID: 28708211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients?
    Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
    AIDS; 2017 Mar; 31(5):661-668. PubMed ID: 28005685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
    Adinolfi LE; Rinaldi L; Nevola R
    World J Gastroenterol; 2018 Nov; 24(41):4617-4621. PubMed ID: 30416309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attempt to calculate the prevalence and features of chronic hepatitis C infection in Tuscany using administrative data.
    Silvestri C; Bartolacci S; Pepe P; Monnini M; Voller F; Cipriani F; Stasi C
    World J Gastroenterol; 2016 Nov; 22(44):9829-9835. PubMed ID: 27956807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodialysis access surgery--is there an increased risk of acquiring hepatitis C virus compared to other elective vascular interventions?
    Assadian A; Assadian O; Holak G; Watkins-Riedel T; Senekowitsch C; Kovarik J; Hagmüller GW
    Vasa; 2008 Feb; 37(1):81-5. PubMed ID: 18512545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow up of sustained viral response after treatment of hepatitis C with pegylated interferon alpha-2a in hemodialysis patients.
    Dzekova P; Asani A; Selim G; Gelev S; Trajceska L; Amitov V; Selja N; Zabzun M; Mena S; Gaseva M; Sikole A
    Int J Artif Organs; 2009 Mar; 32(3):180-4. PubMed ID: 19440994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expert opinion on managing chronic HCV in patients with cardiovascular disease.
    Vassalle C; Petta S; Pepe A; Craxi A; Bondin M; Cacoub P
    Antivir Ther; 2018; 23(Suppl 2):35-46. PubMed ID: 30451152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.
    Komitova RT; Atanasova MV; Pavlova TA; Nyagolov MS; Ivanova AV
    Folia Med (Plovdiv); 2017 Mar; 59(1):70-77. PubMed ID: 28384106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.
    Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1271-7. PubMed ID: 15606388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coeliac disease and C virus-related chronic hepatitis: a non association.
    Gravina AG; Federico A; Masarone M; Cuomo A; Tuccillo C; Loguercio C; Persico M; Romano M
    BMC Res Notes; 2012 Sep; 5():533. PubMed ID: 23009068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C treatment in patients with kidney disease.
    Fabrizi F; Aghemo A; Messa P
    Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus in chronic dialysis patients.
    Natov SN; Pereira BJ
    Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hepatitis C in patients with chronic kidney disease.
    Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
    World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
    Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
    J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making the best of a bad situation: early chronic nosocomial HCV infection.
    Santos C; Herrine SK
    Dig Dis Sci; 2010 Jun; 55(6):1509-11. PubMed ID: 20480237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.